I want more information
What is ThyroidPrint?
A test that avoids unnecessary thyroid surgeries
If you have been diagnosed with an indeterminate thyroid nodule (Bethesda III or IV), your risk of cancer ranges between 15 to 30%. If your ThyroidPrint test result is benign the risk of cancer of your nodule falls to less than 5% and you can forgo a diagnostic surgery.
SIMPLE & EFFECTIVE
ThyroidPrint in numbers
Centers working with us
ThyroidPrint, available worldwide to improve your quality of life
ThyroidPrint is a test clinically validated in the United States and Latin America, developed by GeneproDX. Our mission is to change how indeterminate thyroid nodules are diagnosed and treated worldwide.